Annovis Bio Inc (ANVS)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 45.79M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 10.54
52W Low
$ 1.11
Dividend Yield
0.00%
Beta
1.51
Technicals
50-Day MA
2.5976
200-Day MA
3.2018
52 Week High
10.54
52 Week Low
1.11
About ANVS
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.
Employees
8
Headquarters
Malvern, PA
CEO
Dr. Maria L. Maccecchini Ph.D.
Latest News
We Think Annovis Bio (NYSE:ANVS) Needs To Drive Business Growth Carefully - Yahoo Finance
2025-06-22 • Google News